Piper Sandler Has Lowered Expectations for Vicarious Surgical (NYSE:RBOT) Stock Price

Vicarious Surgical (NYSE:RBOT) had its target price decreased by investment analysts at Piper Sandler from $12.00 to $10.50 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s price objective would suggest a potential downside of 0.19% from the stock’s current price.

Vicarious Surgical Trading Up 15.0 %

Vicarious Surgical stock opened at $10.52 on Wednesday. The stock has a market cap of $62.07 million, a P/E ratio of -1.02 and a beta of 1.02. The company has a fifty day simple moving average of $6.95 and a 200-day simple moving average of $7.64. Vicarious Surgical has a 12-month low of $4.27 and a 12-month high of $21.43.

Vicarious Surgical (NYSE:RBOT) last announced its quarterly earnings results on Monday, August 12th. The company reported ($2.86) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.98) by $0.12. As a group, sell-side analysts forecast that Vicarious Surgical will post -10.07 earnings per share for the current fiscal year.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.